Run time: 49m

  3      0

On-Demand eCasts

20EL-560 On-Demand eCast: Platelet Transfusions. What’s New?

Expiration Date: Aug 5, 2023

Credits: None available.


This program is provided complimentary to AABB members.

Please note: AABB reserves the right to make updates to this program.

How to Claim CE Credit
Complete the evaluation found on the "CE Information" tab after watching the video. By submitting the evaluation, you are attesting to watching the presentation in its entirety.

Recording Program Date: Wednesday, August 5, 2020
Master Program Number: 20EL-560

Educational Track: Technical/Clinical
Topic: Transfusion Medicine
Intended Audience: CEOs, Directors, Hospitals, Hospital Blood Banks, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Physicians, Research Scientists, Residents/Fellows, Scientists, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers
Teaching Level: Intermediate to Advanced

(titles and affiliations at the time of the live program)
Director: Daniela Hermelin, MD, Associate Director of Transfusion Medicine, Saint Louis University Hospital, Saint Louis, MO
Speaker: Simon Stanworth, MA, FRCP (Paeds, UK), PhD, FRCPath, Consultant Hematologist, NHSBT, John Radcliffe Hospital, Oxford University Hospitals NHS Trust & University of Oxford, Oxford, UK

Learning Objectives

After participating in this educational activity, participants should be able to:

  • Explain the study design and findings for a recent international randomized trial of platelets to preterm neonates.
  • Discuss the implications of these findings for practice and research in neonatal medicine.
  • Discuss the broader implications of these findings for platelet transfusion practice and research (beyond neonatal medicine).

Program Description

Platelet Transfusions: What are the Implications of Recent Randomized Trials Including a Study in Neonates? This program will consider the publication of a recent international randomized trial of platelet transfusions to preterm neonates. The speaker will provide a summary of how the study was designed and undertaken and then present the main results. The unexpected finding raises questions not only about how we recommend platelet transfusions should be used in neonates, but also should make us reflect on the consequences of transfusing a platelet component. Platelets are cells that have many functions in addition to hemostasis and clotting.

Please note: a handout is not provided with this program.


  • Dr. Daniela Hermelin, MD, Assistant Professor of Pathology, Director of Therapeutic Apheresis and Associate Director of Transfusion Medicine, Department of Pathology, St. Louis University School of Medicine


  • Simon Stanworth, MA, FRCP (Paeds, UK), PhD, FRCPath, Consultant Hematologist, NHS Blood and Transplant


  • 1.00 - General Continuing Education (GEN)
  • 1.00 - Florida Lab Personnel (FLP)
  • 1.00 - California Nurse (CN)
  • 1.00 - California Lab Personnel (CLP)
  • 1.00 - Physician (PHY)

You must be logged in and own this session in order to post comments.